- Ticagrelor Sulfone
-
-
2026-08-05
- CAS:274693-39-9
- Min. Order: 1KG
- Purity: 98%
- Supply Ability: 1000kg
|
| | Ticagrelor Sulfone Basic information |
| Product Name: | Ticagrelor Sulfone | | Synonyms: | (1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diolcompound with (1S,2S,3R,5S)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cy;Ticagrelor DP5;Ticagrelor impurity 39/(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl) amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl) -5-(2-hydroxyethoxy)cyclopentane-1,2-diol;Ticagrelor-29;1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]aMino]-5-(propylsulfonyl)-3H-1,2,3-triazolo[4,5-d]pyriMidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-;Ticagrelor Sulfone Impurity;(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol;(1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3,4-
difluorophenyl)cyclopropyl)amino)-5-
(propylthio)-3H-[1,2,3]triazolo[4,5-
d]pyrimidin-3-yl)-5-(2-
hydroxyethoxy)cyclopentane-1,2-diol
compound with (1S,2S,3R,5S)-3-(7-
(((1S,2S)-2-(3,4-
difluorophenyl)cyclopropyl)amino | | CAS: | 274693-39-9 | | MF: | C23H28F2N6O6S | | MW: | 554.57 | | EINECS: | | | Product Categories: | | | Mol File: | 274693-39-9.mol |  |
| | Ticagrelor Sulfone Chemical Properties |
| Melting point | 153-156°C | | Boiling point | 819.5±75.0 °C(Predicted) | | density | 1.74±0.1 g/cm3(Predicted) | | storage temp. | Amber Vial, -20°C Freezer, Under inert atmosphere | | solubility | DMSO (Slightly), Methanol (Very Slightly) | | pka | 13.22±0.70(Predicted) | | form | Solid | | color | White to Off-White | | Stability: | Light Sensitive |
| | Ticagrelor Sulfone Usage And Synthesis |
| Uses | Ticagrelor Sulfone is an impurity of ticagrelor (T437700). Ticagrelor, the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS). |
| | Ticagrelor Sulfone Preparation Products And Raw materials |
|